Unimed Diagnostics.Ltd. Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-12-2024
- Paid Up Capital ₹ 0.10 M
as on 12-12-2024
- Company Age 29 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 6.00 M
as on 12-12-2024
- Revenue -15.12%
(FY 2020)
- Profit -156.82%
(FY 2020)
- Ebitda 1127.47%
(FY 2020)
- Net Worth -54.83%
(FY 2020)
- Total Assets 1.95%
(FY 2020)
About Unimed Diagnostics.Ltd.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.00 M.
Ranabir Banerjee and Sanchita Banerjee serve as directors at the Company.
- CIN/LLPIN
U85195WB1995PTC075655
- Company No.
075655
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Nov 1995
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Unimed Diagnostics.Ltd.?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranabir Banerjee  | Director | 29-Nov-1995 | Current |
| Sanchita Banerjee | Director | 23-Dec-2016 | Current |
Financial Performance of Unimed Diagnostics.Ltd..
Unimed Diagnostics Pvt.Ltd., for the financial year ended 2020, experienced significant reduction in revenue, with a 15.12% decrease. The company also saw a substantial fall in profitability, with a 156.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unimed Diagnostics.Ltd.?
In 2019, Unimed Diagnostics.Ltd. had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Siemens Financial Services Private Limited Creation Date: 28 Nov 2013 | ₹1.70 M | Open |
Ge Capital Services India Creation Date: 30 Dec 2011 | ₹0.95 M | Open |
United Bank Of India Creation Date: 21 Jun 2011 | ₹1.50 M | Open |
How Many Employees Work at Unimed Diagnostics.Ltd.?
Unimed Diagnostics.Ltd. has a workforce of 13 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unimed Diagnostics.Ltd., offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimed Diagnostics.Ltd.'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
